Skip to main content
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma.
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
Telomerase expression in primary neuroblastomas.
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results.